News

This trial is designed to evaluate the safety and tolerability of MacuSight’s proprietary formulation of sirolimus when administered in various doses through two different types of ocular injections.

The study will be conducted at the University of Texas MD Anderson Cancer Center. MKC-1 is also being evaluated currently in a phase II clinical study in patients

If successful this trial could represent a breakthrough in influenza vaccines. Sanofi Pasteur will attempt to diversify the influenza vaccine market by basing the vaccines on cell culture

RTP-801 is involved in the development of blood vessels which accelerate the progression of age-related macular degeneration (AMD). Financial terms of the agreement were not announced and the

This award combined with an earlier phase 1 small business innovation research (SBIR) grant award brings total program funding to approximately $2.3 million. The grants will be used

The treatment is developed for patients who are tolerant to opioid therapy for their underlying persistent cancer pain. Fentora is the first and only buccal tablet approved for

The labeling now states that the condition, reversible posterior leukoencephalopathy syndrome (RPLS), could be a potential side-effect after taking Avastin. The rare brain disorder is bleeding syndrome that

Azixa is being developed to treat brain cancer. Azixa represents the first confirmed clinical proof of concept for this new technology, which is the basis for the Epicept's

The vaccine is co-developed with Novartis Vaccines and Diagnostics and has been manufactured to prevent a number of childhood diseases. Following the awarding of licensure by the Korea